Skip to content
Apex Nursing

Reference — Gastrointestinal

Liver Laboratory Values

Quick reference for hepatic laboratory interpretation — hepatocellular injury markers, cholestatic markers, and synthetic function tests with normal ranges and clinical significance.

Educational use only. Reference ranges vary by laboratory and patient population. Always interpret results in the clinical context and per your institution's reference values. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.

Hepatocellular Injury Markers

AST (Aspartate Aminotransferase)Normal: 10–40 U/L
Elevated causesHepatitis (viral, alcoholic, autoimmune), ischemic hepatitis, drug-induced liver injury, muscle injury (myocardial infarction, rhabdomyolysis), hemolysis
Decreased causesB6 deficiency (pyridoxine — cofactor for AST synthesis)
Clinical noteAST:ALT ratio >2:1 with GGT elevation strongly suggests alcoholic hepatitis. Less specific than ALT for hepatic disease (found in heart, muscle, kidney).
ALT (Alanine Aminotransferase)Normal: 7–56 U/L
Elevated causesHepatitis (viral, alcoholic, NASH, autoimmune), drug/toxin-induced liver injury, biliary obstruction, celiac disease
Decreased causesNot clinically significant
Clinical noteMore specific to liver than AST. ALT >10× normal = acute hepatic necrosis (ischemia, acetaminophen toxicity, viral hepatitis). Serial trending more important than single value.
AST:ALT RatioNormal: ~1:1
Elevated causes>2:1 = alcoholic hepatitis (especially with GGT elevation). >3:1 = highly suggestive of alcohol etiology.
Decreased causesNot applicable
Clinical noteUseful pattern: ALT > AST in viral hepatitis. AST > ALT in alcoholic hepatitis (alcohol depletes pyridoxine needed for ALT synthesis).

Cholestatic / Biliary Markers

ALP (Alkaline Phosphatase)Normal: 44–147 U/L (adult)
Elevated causesBiliary obstruction (choledocholithiasis, cholangiocarcinoma, PSC, PBC), liver metastases, Paget's disease of bone, bone growth (adolescents), pregnancy (placental ALP)
Decreased causesZinc deficiency, hypothyroidism, pernicious anemia, cardiac surgery with bypass
Clinical noteALP alone does not diagnose liver disease — must correlate with GGT. Isolated elevated ALP with elevated GGT = biliary/hepatic source. Isolated ALP = consider bone disease.
GGT (Gamma-Glutamyl Transferase)Normal: 8–61 U/L (M); 5–36 U/L (F)
Elevated causesAlcohol use (sensitive marker for chronic use), biliary obstruction, liver disease, pancreatitis, drug-induced liver injury (phenytoin, carbamazepine)
Decreased causesNot clinically significant
Clinical noteMost sensitive liver enzyme for alcohol use. GGT + elevated ALP = biliary disease. GGT elevated with normal ALP = consider alcohol.
Total BilirubinNormal: 0.2–1.2 mg/dL
Elevated causesHepatic: hepatitis, cirrhosis, cholestasis. Prehepatic: hemolysis, ineffective erythropoiesis. Posthepatic: bile duct obstruction. Jaundice visible when >2.5 mg/dL.
Decreased causesNot clinically significant
Clinical noteDistinguish indirect (unconjugated, prehepatic) vs direct (conjugated, hepatic/posthepatic) bilirubin. Dark urine + jaundice = direct hyperbilirubinemia (conjugated = water-soluble).
Direct Bilirubin (Conjugated)Normal: 0–0.3 mg/dL
Elevated causesHepatocellular disease (hepatitis, cirrhosis), biliary obstruction (gallstones, malignancy), Dubin-Johnson syndrome
Decreased causesNot applicable
Clinical noteElevated direct bilirubin = problem conjugating or excreting bilirubin. Associated with dark (tea-colored) urine and clay-colored stools in biliary obstruction.
Indirect Bilirubin (Unconjugated)Normal: 0.2–0.9 mg/dL
Elevated causesHemolysis (sickle cell, transfusion reaction, autoimmune hemolytic anemia), Gilbert's syndrome, Crigler-Najjar syndrome, neonatal jaundice
Decreased causesNot applicable
Clinical noteElevated indirect bilirubin = unconjugated (fat-soluble). Does NOT appear in urine (not water-soluble). Stool color normal (conjugation and excretion are intact).

Hepatic Synthetic Function

AlbuminNormal: 3.5–5.0 g/dL
Elevated causesDehydration (hemoconcentration) — not a clinically significant elevation
Decreased causesCirrhosis and liver failure (decreased synthesis), malnutrition, nephrotic syndrome (urinary losses), severe burns, protein-losing enteropathy, malabsorption
Clinical noteAlbumin half-life = 20 days — reflects chronic liver function, not acute. Better marker of chronic disease severity than acute injury. Low albumin = ascites risk (decreased oncotic pressure).
INR (International Normalized Ratio)Normal: 0.8–1.2
Elevated causesLiver disease (decreased factor synthesis), warfarin therapy, DIC, vitamin K deficiency (malabsorption, prolonged antibiotics), massive blood transfusion
Decreased causesNot clinically significant
Clinical noteINR reflects hepatic synthesis of clotting factors II, VII, IX, X, and Protein C/S. INR is part of the MELD score for liver transplant prioritization. Elevated INR ≠ always anticoagulated — check clinical context.
PT (Prothrombin Time)Normal: 11–13.5 seconds
Elevated causesSame as INR — liver failure, warfarin, DIC, vitamin K deficiency. More sensitive to factor VII (short half-life 4–6 hours) = early marker of acute liver failure.
Decreased causesNot clinically significant
Clinical notePT/INR are the best markers of acute hepatic synthetic failure. In acute liver failure, PT >15 sec or INR >1.5 indicates significant synthetic impairment.
AmmoniaNormal: 15–45 mcg/dL (may vary by lab)
Elevated causesHepatic encephalopathy (liver failure impairs urea cycle), GI bleed (blood = protein substrate), constipation, high-protein diet, urease-producing bacteria (H. pylori, UTI), renal failure
Decreased causesNot clinically significant in isolation
Clinical noteElevated ammonia alone does not diagnose HE — must correlate with clinical presentation. Ammonia does not reliably track HE severity. Arterial ammonia more reliable than venous.

Related Resources

Standards & sources

Fact-checked Jun 21, 2026

This page is written to align with American College of Gastroenterology (ACG) / AGA · ASPEN (nutrition support). It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →